Jennison Associates’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-66,568
| Closed | -$493K | – | 606 |
|
|
2024
Q4 | $493K | Buy |
+66,568
| New | +$493K | ﹤0.01% | 558 |
|
|
2024
Q3 | – | Sell |
-58,084
| Closed | -$466K | – | 592 |
|
|
2024
Q2 | $466K | Buy |
58,084
+8,055
| +16% | +$64.6K | ﹤0.01% | 552 |
|
|
2024
Q1 | $741K | Sell |
50,029
-41,126
| -45% | -$609K | ﹤0.01% | 526 |
|
|
2023
Q4 | $741K | Buy |
+91,155
| New | +$741K | ﹤0.01% | 524 |
|
|
2021
Q1 | – | Sell |
-336,986
| Closed | -$15.6M | – | 693 |
|
|
2020
Q4 | $15.6M | Sell |
336,986
-9,496
| -3% | -$441K | 0.01% | 361 |
|
|
2020
Q3 | $11.4M | Buy |
346,482
+1,243
| +0.4% | +$40.9K | 0.01% | 363 |
|
|
2020
Q2 | $9.48M | Buy |
+345,239
| New | +$9.48M | 0.01% | 377 |
|